NYSE: MKC

MCCORMICK & CO INC

CIK 0000063754 · Consumer Staples · SIC 2090 · Food Preparations

Large Revenue $6.8B Assets $16.5B as of Aug 2, 2026

Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.

Sign up free

Want to see a complete report first? Today's free report (TEAD 10-Q) is open in full — no account needed.

10-Q Filed Jun 25, 2026 · Period ending May 31, 2026

McCormick announces $15.7B Unilever Foods merger, diluting shareholders to 35% stake

5 material changes detected. Sign up free to read the summary.

8-K Filed Jun 25, 2026 · Period ending Jun 25, 2026

McCormick reports Q2 2026 earnings, reaffirms outlook, updates Unilever Foods integration

5 material changes detected. Sign up free to read the summary.

Partner

Trade MKC commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed May 26, 2026 · Period ending May 19, 2026

McCormick appoints former AstraZeneca digital chief Cindy Hoots to Board

2 material changes detected. Sign up free to read the summary.

8-K Filed May 1, 2026 · Period ending Apr 28, 2026

McCormick secures $2B term loan, reduces bridge facility for up to $15.7B Unilever foods acquisition

5 material changes detected. Sign up free to read the summary.

8-K Filed Apr 17, 2026 · Period ending Apr 15, 2026

Summary not yet generated.

10-Q Filed Mar 31, 2026 · Period ending Feb 28, 2026

Summary not yet generated.

424B3 Filed Mar 26, 2026

Summary not yet generated.

424B5 Filed Feb 3, 2026

Summary not yet generated.

10-K Filed Jan 22, 2026 · Period ending Nov 30, 2025

Summary not yet generated.

10-Q Filed Jun 26, 2025 · Period ending May 31, 2025

Summary not yet generated.

10-K Filed Jan 23, 2025 · Period ending Nov 30, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Jun 25, 2026 (period ending May 31, 2026). SEC XBRL (companyfacts) — not generated by the model.

SEC XBRL

Consolidated Statements of Operations (Unaudited)

Description Q2 ended May 31, 2026 Q2 ended May 31, 2025
Revenue:
Total revenue / net sales 1,937 1,660
Cost of revenue / cost of sales 1,158 1,037
Gross profit 778.2 622.8
Operating expenses:
Selling, general and administrative 441.8 364.2
Other operating expenses, net 60.0 12.8
Operating income 276.4 245.8
Interest expense 62.7 51.0
Other income/(expense), net 6.5 9.8
Income before income taxes 220.2 204.6
Income tax expense/(benefit) 63.5 49.3
Net income 150.1 175.0
Basic earnings per share 0.56 0.65
Diluted earnings per share 0.56 0.65

Consolidated Balance Sheets (Unaudited)

Description May 31, 2026 May 31, 2025
Current assets:
Cash and equivalents 331.2 124.1
Accounts receivable, net 709.4 584.5
Prepaid expenses and other current assets 339.6 150.2
Other current assets 1,409 1,308
Total current assets 2,789 2,166
Property, plant and equipment, net 1,504 1,417
Identifiable intangible assets, net 4,938 3,309
Goodwill 6,292 5,292
Other long-term assets 954.7 1,007
TOTAL ASSETS 16,477 13,190
Current liabilities:
Current portion of long-term debt 9.5 756.7
Line of credit 1,327 598.9
Other current liabilities 2,236 1,830
Total current liabilities 3,572 3,186
Long-term debt 3,597 3,099
Deferred income taxes and other liabilities 1,327 823.0
Other long-term liabilities 407.6 452.0
Total liabilities 8,904 7,560
Shareholders' equity:
Accumulated other comprehensive income (loss) (161.4) (401.2)
Retained earnings (deficit) 4,843 3,739
Total shareholders' equity 6,996 5,601
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 16,477 13,190

Consolidated Statements of Cash Flows (Unaudited)

Description Six months ended May 31, 2026 Six months ended May 31, 2025
Operating Activities:
Net cash from operating activities 430.7 161.4
Investing Activities:
Net cash from investing activities (805.1) (105.2)
Financing Activities:
Net cash from financing activities 602.7 (142.9)
Net increase/(decrease) in cash 235.3 (62.0)

Amounts in millions USD; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗

View AI report for this filing